{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:27:17Z","timestamp":1790126837253,"version":"4.0.1"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T00:00:00Z","timestamp":1470787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"name":"Catalysis Foundation for Health","award":["OPP51919"],"award-info":[{"award-number":["OPP51919"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0160062","type":"journal-article","created":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T22:02:44Z","timestamp":1470866564000},"page":"e0160062","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":40,"title":["Bacterial Loads Measured by the Xpert MTB\/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB"],"prefix":"10.1371","volume":"11","author":[{"given":"Shubhada","family":"Shenai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Ronacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanus","family":"Malherbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Kriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Peppard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori E.","family":"Dodd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Via","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifton E.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Walzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Alland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,8,10]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1183\/09031936.00007410","article-title":"Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis","volume":"37","author":"WJ Su","year":"2011","journal-title":"The European respiratory journal"},{"issue":"5","key":"ref2","first-page":"560","article-title":"Baseline sputum time to detection predicts month two culture conversion and relapse in non-HIV-infected patients","volume":"14","author":"AC Hesseling","year":"2010","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"e0125403","DOI":"10.1371\/journal.pone.0125403","article-title":"Month 2 culture status and treatment duration as predictors of recurrence in pulmonary tuberculosis: model validation and update","volume":"10","author":"RS Wallis","year":"2015","journal-title":"PloS one"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S2213-2600(15)00036-3","article-title":"Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies","volume":"3","author":"EV Kurbatova","year":"2015","journal-title":"The Lancet Respiratory medicine"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1473-3099(10)70071-2","article-title":"Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis","volume":"10","author":"DJ Horne","year":"2010","journal-title":"The Lancet infectious diseases"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12916-016-0565-y","article-title":"Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trials","volume":"14","author":"PP Phillips","year":"2016","journal-title":"BMC medicine"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/CMR.00059-10","article-title":"Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities","volume":"24","author":"LM Parsons","year":"2011","journal-title":"Clinical microbiology reviews"},{"issue":"Suppl 1","key":"ref8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature05448","article-title":"Requirements for high impact diagnostics in the developing world","volume":"444","author":"M Urdea","year":"2006","journal-title":"Nature"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1371\/journal.pmed.0040120","article-title":"Why is long-term therapy required to cure tuberculosis?","volume":"4","author":"LE Connolly","year":"2007","journal-title":"PLoS medicine"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1473-3099(07)70112-3","article-title":"Biomarkers of treatment response in clinical trials of novel antituberculosis agents","volume":"7","author":"FM Perrin","year":"2007","journal-title":"The Lancet infectious diseases"},{"issue":"7","key":"ref11","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1128\/JCM.00128-10","article-title":"Evaluation of the analytical performance of the Xpert MTB\/RIF assay","volume":"48","author":"R Blakemore","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"11","key":"ref12","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa0907847","article-title":"Rapid molecular detection of tuberculosis and rifampin resistance","volume":"363","author":"CC Boehme","year":"2010","journal-title":"The New England journal of medicine"},{"issue":"9","key":"ref13","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1164\/rccm.201103-0536OC","article-title":"A multisite assessment of the quantitative capabilities of the Xpert MTB\/RIF assay","volume":"184","author":"R Blakemore","year":"2011","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/JCM.01463-09","article-title":"Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology","volume":"48","author":"D Helb","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S2213-2600(13)70119-X","article-title":"Assessment of the sensitivity and specificity of Xpert MTB\/RIF assay as an early sputum biomarker of response to tuberculosis treatment","volume":"1","author":"SO Friedrich","year":"2013","journal-title":"The Lancet Respiratory medicine"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1128\/JCM.03290-12","article-title":"Direct comparison of Xpert MTB\/RIF assay with liquid and solid mycobacterial culture for quantification of early bactericidal activity","volume":"51","author":"XA Kayigire","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2213-2600(13)70133-4","article-title":"Xpert MTB\/RIF: monitoring response to tuberculosis treatment","volume":"1","author":"MP Nicol","year":"2013","journal-title":"The Lancet Respiratory medicine"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1128\/JCM.01053-10","article-title":"Containment of bioaerosol infection risk by the Xpert MTB\/RIF assay and its applicability to point-of-care settings","volume":"48","author":"PP Banada","year":"2010","journal-title":"J Clin Microbiol"},{"key":"ref19","author":"PT K","year":"1985"},{"key":"ref20","article-title":"Definition and Reporting Framework for Tuberculosis-2013 revision","volume":"2013","year":"2013"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.0006-341X.2002.00657.x","article-title":"Combining several screening tests: Optimality of the risk score","volume":"58","author":"MW McIntosh","year":"2002","journal-title":"Biometrics"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1378\/chest.113.2.379","article-title":"Time to detection of Mycobacterium tuberculosis in sputum culture correlates with outcome in patients receiving treatment for pulmonary tuberculosis","volume":"113","author":"MD Epstein","year":"1998","journal-title":"Chest"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1128\/AAC.01876-12","article-title":"A time-to-event pharmacodynamic model describing treatment response in patients with pulmonary tuberculosis using days to positivity in automated liquid mycobacterial culture","volume":"57","author":"E Chigutsa","year":"2013","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"12","key":"ref24","doi-asserted-by":"crossref","first-page":"e28815","DOI":"10.1371\/journal.pone.0028815","article-title":"Comparison of quantitative techniques including Xpert MTB\/RIF to evaluate mycobacterial burden","volume":"6","author":"RN van Zyl-Smit","year":"2011","journal-title":"PloS one"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1473-3099(10)70003-7","article-title":"Biomarkers for tuberculosis disease activity, cure, and relapse","volume":"10","author":"RS Wallis","year":"2010","journal-title":"The Lancet infectious diseases"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0160062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T13:28:13Z","timestamp":1540042093000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0160062"}},"subtitle":[],"editor":[{"given":"Oilvier","family":"Neyrolles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,8,10]]},"references-count":25,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0160062","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,10]]}}}